LeafNLP Demos
Back to explore

Report #2866529

Received Oct 17, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
63 yrs
State
TX
Recovered
Unknown
Vaccinated
Jul 31, 2025
Onset
Jul 31, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK429P7—

Symptoms (1)

Product preparation issue

Symptom narrative

patient was possible given diluent only instead of reconstituted vaccine; patient was possible given diluent only instead of reconstituted vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 63-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 429P7) for prophylaxis. On 31-JUL-2025, the patient received Arexvy. On 31-JUL-2025, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient was possible given diluent only instead of reconstituted vaccine) and inappropriate dose of vaccine administered (Verbatim: patient was possible given diluent only instead of reconstituted vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-SEP-2025 Pharmacist explained that a patient was possible given diluent only instead of reconstituted vaccine of Arexvy.